Bicara Therapeutics Inc.
NASDAQBCAX enters its August 12 earnings event in an unusual position: short sellers have been cutting exposure even as the company's own executives took profits at the top. Short interest has dropped sharply — down 6.4% on the week and 11.1% over the past month, pulling the short position from above 10.5 million shares in early July to roughly 9.5 million now, equal to 17.3% of the free…
Snapshot as of 1 Aug 2026
BCAX enters its August 12 earnings event in an unusual position: short sellers have been cutting exposure even as the company's own executives took profits at the top. Short interest has dropped sharply — down 6.4% on…
Short interest updated daily, real-time options flow, analyst consensus deltas, 13F positioning, ORTEX Alpha signals, and every article ORTEX publishes for BCAX — free to start on ORTEX.
Sign up for free →Open BCAX on ORTEX